Morishita Jintan Co., Ltd. (TYO:4524)
2,225.00
-26.00 (-1.16%)
Jan 21, 2026, 3:12 PM JST
Morishita Jintan Revenue
Morishita Jintan had revenue of 3.17B JPY in the quarter ending September 30, 2025, with 6.80% growth. This brings the company's revenue in the last twelve months to 12.90B, up 3.23% year-over-year. In the fiscal year ending March 31, 2025, Morishita Jintan had annual revenue of 12.77B with 2.90% growth.
Revenue (ttm)
12.90B
Revenue Growth
+3.23%
P/S Ratio
0.71
Revenue / Employee
36.23M
Employees
356
Market Cap
9.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.77B | 360.00M | 2.90% |
| Mar 31, 2024 | 12.41B | 1.05B | 9.22% |
| Mar 31, 2023 | 11.36B | 1.80B | 18.78% |
| Mar 31, 2022 | 9.56B | 134.00M | 1.42% |
| Mar 31, 2021 | 9.43B | -345.00M | -3.53% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |